by Scott Creighton
Good morning.
German based BioNTech is in the process of testing a new lung cancer 'vaccine' called BNT116 which is based on the mRNA model they helped bring about with the Covid-19 'vaccines' they made in partnership with Pfizer.
It's for non-small cell lung cancer (NSCLC)
'Drawing on technologies used in the creation of COVID-19 immunizations, BioNTech launched its first clinical trials involving the new vaccine in August 2024. While media outlets praised the trials for their promise and potential, most of the coverage has focused on the company’s skyrocketing valuations, leaving many to wonder how the vaccine actually works on a scientific level, why it arrived at the time that it did, and when (if ever) it will become a widely available form of treatment...
“The role of mRNA is to carry protein information from the DNA in a cell’s nucleus to the cell’s cytoplasm (watery interior),” notes the National Human Genome Research Institute, “where the protein-making machinery reads the mRNA sequence and translates each three-base codon [sequences made up of the DNA molecules adenine (A), cytosine (C), guanine (G), and thymine (T)] into its corresponding amino acid in a growing protein chain.” Big Think
This is reported as being very exciting news for the Western world hailing the glorious mRNA tech as some kind of VunderDrug (sieg heil) which only killed million or so test subjects to work out the kinks.
However... Cuba has had a working, safe, well tested NSCLC vaccine on the market... since 2011. And oh yeah... it costs about a dollar to produce... and the ebil soOOoooOoocialist country... gives it to their people (and you to if you can get there)... for free.
Damn commies. How dare they ignore profits?!?